Pliant Therapeutics
Price & Volume
Stats
See more52W Range | $1.26-$16.52 |
Market Cap | $99.2M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.47 |
News
See moreYahoo Finance • yesterday
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
Yahoo Finance • 7 days ago
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
Yahoo Finance • 26 days ago
Pliant Therapeutics, Inc. Company Investigated by the Portnoy Law Firm
About
CEO | Dr. Bernard Coulie M.B.A., M.D., Ph.D. |
Address | 260 Littlefield Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 171 |
